2017-03-16,Merus Named BioCapital Europe 2017 Company Of The Year
2017-02-27,Merus To Present At The Cowen & Co. 37th Annual Health Care Conference
2017-02-09,Merus To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-01-23,Merus Announces Closing Of Global Strategic Research Collaboration With Incyte To Discover And Develop Bispecific Antibodies
2017-01-05,Merus And The Institute For Research In Biomedicine (IRB) Barcelona Form Research Collaboration To Develop Bispecific Antibodies Targeting The Tumor Microenvironment
2016-12-21,Incyte And Merus Announce Global Strategic Research Collaboration To Discover And Develop Bispecific Antibodies
2016-11-15,Merus Announces Favorable Decisions In Europe And Japan For Patents Covering Genetically-Modified Mice For Common Light Chain Human Monoclonal Antibodies
2016-11-10,Merus To Present At The Jefferies London Healthcare Conference
2016-11-09,Merus N.V. Receives €1.5 Million EUREKA Eurostars Grant With Aquila BioMedical Ltd To Jointly Develop Immunological Assays For Identification Of Novel Immunomodulatory Bispecific Antibodies
2016-11-07,Merus Announces Third Quarter 2016 Financial Results And Corporate Developments
2016-11-03,Merus Strengthens Executive Management Team With The Appointment Of John Crowley As Chief Financial Officer
2016-10-26,Merus Expands Executive Management Team With The Appointment Of L. Andres Sirulnik, MD, PhD, As Chief Medical Officer
2016-10-19,Merus Receives Milestone Payment From Ono Pharmaceutical For Selection Of Bispecific Antibody Candidate For Clinical Development And Extends Partnership With CMC Service Agreement
2016-08-31,Merus To Participate In Upcoming Investor Conferences
2016-08-10,Merus To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-08,Merus Announces Second Quarter 2016 Financial Results And Reviews Recent Clinical Progress And Corporate Developments
2016-07-12,Merus Announces First Quarter 2016 Financial Results And Highlights Recent Clinical Progress And Corporate Developments
2016-06-03,What You Need to Know About Biotech IPOs This Year
2016-06-01,Merus N.V. Signs Commercial Multi-Product License For ProBioGen's GlymaxX® ADCC Enhancement Technology
2016-05-31,Merus N.V. Announces Closing Of Partial Exercise Of Underwriters' Over-Allotment Option
2016-05-24,Merus N.V. Announces Closing Of Initial Public Offering
,
,
,
,
,
2017-03-16,Merus Named BioCapital Europe 2017 Company Of The Year
2017-02-27,Merus To Present At The Cowen & Co. 37th Annual Health Care Conference
2017-02-09,Merus To Present At The Leerink Partners 6th Annual Global Healthcare Conference
2017-01-23,Merus Announces Closing Of Global Strategic Research Collaboration With Incyte To Discover And Develop Bispecific Antibodies
2017-01-05,Merus And The Institute For Research In Biomedicine (IRB) Barcelona Form Research Collaboration To Develop Bispecific Antibodies Targeting The Tumor Microenvironment
2016-12-21,Incyte And Merus Announce Global Strategic Research Collaboration To Discover And Develop Bispecific Antibodies
2016-11-15,Merus Announces Favorable Decisions In Europe And Japan For Patents Covering Genetically-Modified Mice For Common Light Chain Human Monoclonal Antibodies
2016-11-10,Merus To Present At The Jefferies London Healthcare Conference
2016-11-09,Merus N.V. Receives €1.5 Million EUREKA Eurostars Grant With Aquila BioMedical Ltd To Jointly Develop Immunological Assays For Identification Of Novel Immunomodulatory Bispecific Antibodies
2016-11-07,Merus Announces Third Quarter 2016 Financial Results And Corporate Developments
2016-11-03,Merus Strengthens Executive Management Team With The Appointment Of John Crowley As Chief Financial Officer
2016-10-26,Merus Expands Executive Management Team With The Appointment Of L. Andres Sirulnik, MD, PhD, As Chief Medical Officer
2016-10-19,Merus Receives Milestone Payment From Ono Pharmaceutical For Selection Of Bispecific Antibody Candidate For Clinical Development And Extends Partnership With CMC Service Agreement
2016-08-31,Merus To Participate In Upcoming Investor Conferences
2016-08-10,Merus To Present At The 2016 Wedbush PacGrow Healthcare Conference
2016-08-08,Merus Announces Second Quarter 2016 Financial Results And Reviews Recent Clinical Progress And Corporate Developments
2016-07-12,Merus Announces First Quarter 2016 Financial Results And Highlights Recent Clinical Progress And Corporate Developments
2016-06-03,What You Need to Know About Biotech IPOs This Year
2016-06-01,Merus N.V. Signs Commercial Multi-Product License For ProBioGen's GlymaxX® ADCC Enhancement Technology
2016-05-31,Merus N.V. Announces Closing Of Partial Exercise Of Underwriters' Over-Allotment Option
2016-05-24,Merus N.V. Announces Closing Of Initial Public Offering
,
,
,
,
,
